GlassScriptPhysician profile
Roshinder Padda
NPI 1932107117
$2,650.54
in general payments reported to CMS, 2019-2025
28 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $273 · 2021: $35.28 · 2022: $384 · 2023: $626 · 2024: $151 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.34 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $505.15 | 2019-2024 | Veozah, Myrbetriq |
| Amgen INC. | $383.37 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $243.87 | 2019-2023 | |
| Therapeuticsmd, INC. | $201.67 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $196.49 | 2022-2025 | |
| Abbvie INC. | $171.36 | 2019 | |
| Sumitomo Pharma America, INC. | $140.23 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $139.61 | 2020-2023 | Ova1 |
| Amag Pharmaceuticals, INC. | $100.60 | 2019-2020 | |
| Millicent US INC | $73.52 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Caldera Medical, INC | $53.85 | 2023 | Desara |
| Intuitive Surgical, INC. | $51.57 | 2022 | |
| Channel Medsystems, INC. | $51.01 | 2023 | |
| Lupin INC. | $50.37 | 2019-2020 | |
| Boston Scientific Corporation | $35.62 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $32.90 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $32.75 | 2024-2025 | |
| Novo Nordisk INC | $26.23 | 2025 | |
| Duchesnay USA Incorporated | $22.71 | 2019 | |
| Coopersurgical, INC. | $20.32 | 2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $18.94 | 2019 | |
| Exeltis, USA INC. | $18.36 | 2025 | Slynd |
| Radius Health, INC. | $17.98 | 2019 | |
| Allergan, INC. | $14.47 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.61 | 2020 | |
| Smith+Nephew, INC. | $12.09 | 2019 | |
| Novum Pharma, LLC | $11.76 | 2019 | |
| Janssen Biotech, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshinder Padda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.